Larvol Delta - HARMONiGU1-A-Study-of-Ivonescimab-in-Combination-With-Enfortumab-Vedotin-vs-Pembrolizumab-in-Combination-With-Enfortumab-Vedotin-in-Metastatic-Urothelial-Carcinoma

Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer

Idafang (ivonescimab) - Summit Therapeutics

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT07815665

Sep 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next